| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |